Poseida Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2023-08-11: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2023-08-07; Total offering amount $24,999,999.
- 2019-04-22: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-19; Total offering amount $150,000,000.
- 2018-04-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-03-19; Total offering amount $30,499,990.
- 2017-08-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2017-07-21; Total offering amount $15,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Rule 506(b) | Equity | 2023-08-07 | $24,999,999 | $24,999,999 | $0 | 1 |
| 2019-04-22 | Rule 506(b) | Equity | 2019-03-19 | $150,000,000 | $142,120,007 | $7,879,993 | 17 |
| 2018-04-03 | Rule 506(b) | Equity | 2018-03-19 | $30,499,990 | $30,499,990 | $0 | 7 |
| 2017-08-03 | Rule 506(b) | Equity | 2017-07-21 | $15,000,000 | $11,160,002 | $3,839,998 | 16 |
| 2015-12-24 | Rule 506(b) | Equity | 2015-12-15 | $36,033,230 | $23,033,232 | $12,999,998 | 14 |